• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植中心之间临床因素与早期停用类固醇选择之间关联的不一致性:一项全国性登记研究。

Inconsistencies in the association of clinical factors with the choice of early steroid withdrawal across kidney transplant centers: A national registry study.

作者信息

Bae Sunjae, Garonzik-Wang Jacqueline M, Massie Allan B, McAdams-DeMarco Mara A, Coresh Josef, Segev Dorry L

机构信息

Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

出版信息

Clin Transplant. 2021 Feb;35(2):e14176. doi: 10.1111/ctr.14176. Epub 2020 Dec 12.

DOI:10.1111/ctr.14176
PMID:33259086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8284554/
Abstract

BACKGROUND

Approximately 30% of kidney transplant recipients undergo early steroid withdrawal (ESW) for maintenance immunosuppression. However, there is no consensus on which patients are suitable for ESW, and transplant centers may disagree on how various clinical factors characterize individual recipients' suitability for ESW.

METHODS

To examine center-level variation in the association of clinical factors with the choice of ESW, we studied 206 544 kidney transplant recipients from 278 centers in 2002-2017 using SRTR data. We conducted multi-level logistic regressions to characterize the association of clinical factors with the choice of ESW at each transplant center.

RESULTS

The association of clinical factors with the choice of ESW varied substantially across centers. We found particularly greater inconsistency in recipient age, PRA, re-transplantation, living/deceased donor, post-transplant length of stay, and delayed graft function. For example, across the entire population, re-transplantation was associated with lower odds of ESW (population odds ratio =  0.40 ). When estimated at each center, this odds ratio was significantly lower than the population odds ratio at 48 (17.3%) centers and significantly higher at 28 (10.1%) centers.

CONCLUSIONS

We have observed apparent inconsistencies across transplant centers in the practice of tailoring ESW to the recipient's risk profile. Standardized guidelines for ESW tailoring are needed.

摘要

背景

约30%的肾移植受者在维持免疫抑制治疗时接受早期停用类固醇(ESW)。然而,对于哪些患者适合ESW尚无共识,而且各移植中心对于各种临床因素如何界定个体受者是否适合ESW可能存在分歧。

方法

为研究临床因素与ESW选择之间关联在中心层面的差异,我们利用器官获取与移植网络(SRTR)数据,对2002年至2017年来自278个中心的206544例肾移植受者进行了研究。我们进行了多层次逻辑回归分析,以描述每个移植中心临床因素与ESW选择之间的关联。

结果

临床因素与ESW选择之间的关联在各中心之间存在很大差异。我们发现,在受者年龄、群体反应性抗体(PRA)、再次移植、活体/已故供体、移植后住院时间以及移植肾功能延迟恢复等方面,不一致性尤为明显。例如,在整个人群中,再次移植与ESW几率较低相关(总体优势比=0.40)。在每个中心进行估计时,这一优势比在48个(17.3%)中心显著低于总体优势比,在28个(10.1%)中心显著高于总体优势比。

结论

我们观察到,在根据受者风险状况调整ESW的实践中,各移植中心存在明显的不一致。需要制定ESW调整的标准化指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c86c/8284554/720caa2bcdab/nihms-1718640-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c86c/8284554/709905bed3a4/nihms-1718640-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c86c/8284554/720caa2bcdab/nihms-1718640-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c86c/8284554/709905bed3a4/nihms-1718640-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c86c/8284554/720caa2bcdab/nihms-1718640-f0002.jpg

相似文献

1
Inconsistencies in the association of clinical factors with the choice of early steroid withdrawal across kidney transplant centers: A national registry study.肾移植中心之间临床因素与早期停用类固醇选择之间关联的不一致性:一项全国性登记研究。
Clin Transplant. 2021 Feb;35(2):e14176. doi: 10.1111/ctr.14176. Epub 2020 Dec 12.
2
Early steroid withdrawal in HIV-infected kidney transplant recipients: Utilization and outcomes.HIV 感染肾移植受者的早期类固醇撤药:利用和结果。
Am J Transplant. 2021 Feb;21(2):717-726. doi: 10.1111/ajt.16195. Epub 2020 Aug 13.
3
Panel-reactive Antibody and the Association of Early Steroid Withdrawal With Kidney Transplant Outcomes.Panel-reactive Antibody 与早期激素撤停对肾移植结局的关联。
Transplantation. 2022 Mar 1;106(3):648-656. doi: 10.1097/TP.0000000000003777.
4
Early Steroid Withdrawal in Deceased-Donor Kidney Transplant Recipients with Delayed Graft Function.移植肾功能延迟恢复的 deceased-donor 肾移植受者的早期类固醇撤药。
J Am Soc Nephrol. 2020 Jan;31(1):175-185. doi: 10.1681/ASN.2019040416. Epub 2019 Dec 18.
5
Early steroid withdrawal and kidney transplant outcomes in first-transplant and retransplant recipients.首次移植和再次移植受者的早期停用类固醇与肾移植结局
Nephrol Dial Transplant. 2025 Apr 1;40(4):662-670. doi: 10.1093/ndt/gfae218.
6
Early steroid withdrawal results in improved patient and graft survival and lower risk of post-transplant cardiovascular risk profiles: A single-center 10-year experience.早期停用类固醇可改善患者及移植物存活率,并降低移植后心血管风险状况:一项单中心10年经验。
Clin Transplant. 2017 Feb;31(2). doi: 10.1111/ctr.12878. Epub 2017 Jan 24.
7
Assessing Long-Term Adverse Outcomes in Older Kidney Transplant Recipients: A Propensity Score-Matched Comparison of Early Steroid Withdrawal Versus Continuous Steroid Immunosuppression Using a Large Real-World Database.评估老年肾移植受者的长期不良结局:使用大型真实世界数据库进行的早期撤激素与持续激素免疫抑制的倾向评分匹配比较。
Drugs Aging. 2024 Nov;41(11):915-927. doi: 10.1007/s40266-024-01147-4. Epub 2024 Oct 17.
8
Patient and Graft Survival Outcomes During 2 Eras of Immunosuppression Protocols in Kidney Transplantation: Indiana University Retrospective Cohort Experience.在两个免疫抑制方案时代的肾移植中患者和移植物的生存结果:印第安纳大学回顾性队列经验。
Transplant Proc. 2021 Dec;53(10):2841-2852. doi: 10.1016/j.transproceed.2021.09.030. Epub 2021 Nov 10.
9
Early Steroid Withdrawal in Recipients of a Kidney Transplant From a Living Donor: Experience of a Single Mexican Center.活体供肾肾移植受者早期停用类固醇:墨西哥单一中心的经验
Transplant Proc. 2016 Jan-Feb;48(1):42-9. doi: 10.1016/j.transproceed.2015.12.013.
10
Early steroid withdrawal in adult kidney transplantation at a single center.单中心成人肾移植早期停用类固醇激素
Transplant Proc. 2012 Jan;44(1):179-81. doi: 10.1016/j.transproceed.2011.12.068.

引用本文的文献

1
Posttransplant Diabetes Mellitus and Immunosuppression Selection in Older and Obese Kidney Recipients.老年及肥胖肾移植受者的移植后糖尿病与免疫抑制方案选择
Kidney Med. 2021 Oct 22;4(1):100377. doi: 10.1016/j.xkme.2021.08.012. eCollection 2022 Jan.

本文引用的文献

1
OPTN/SRTR 2018 Annual Data Report: Kidney.OPTN/SRTR 2018 年度数据报告:肾脏。
Am J Transplant. 2020 Jan;20 Suppl s1:20-130. doi: 10.1111/ajt.15672.
2
Early Steroid Withdrawal in Deceased-Donor Kidney Transplant Recipients with Delayed Graft Function.移植肾功能延迟恢复的 deceased-donor 肾移植受者的早期类固醇撤药。
J Am Soc Nephrol. 2020 Jan;31(1):175-185. doi: 10.1681/ASN.2019040416. Epub 2019 Dec 18.
3
Discrimination and Calibration of Clinical Prediction Models: Users' Guides to the Medical Literature.临床预测模型的判别与校准:医学文献的使用者指南。
JAMA. 2017 Oct 10;318(14):1377-1384. doi: 10.1001/jama.2017.12126.
4
Belatacept Compared With Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study.肾移植中贝拉西普与他克莫司的比较:一项倾向评分匹配队列研究。
Transplantation. 2017 Oct;101(10):2582-2589. doi: 10.1097/TP.0000000000001589.
5
Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study.基于初始免疫抑制方案的肾移植术后3年不良结局的差异风险:一项全国性研究。
Transpl Int. 2016 Nov;29(11):1226-1236. doi: 10.1111/tri.12850. Epub 2016 Sep 28.
6
National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence-Based Regimen Selection.肾移植免疫抑制使用的全国性差异:呼吁基于证据的方案选择。
Am J Transplant. 2016 Aug;16(8):2453-62. doi: 10.1111/ajt.13758. Epub 2016 Mar 31.
7
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.在观察性研究中,利用倾向得分采用治疗权重的逆概率(IPTW)估计因果治疗效果时,朝着最佳实践迈进。
Stat Med. 2015 Dec 10;34(28):3661-79. doi: 10.1002/sim.6607. Epub 2015 Aug 3.
8
Moving Beyond Minimization Trials in Kidney Transplantation.超越肾移植中的最小化试验
J Am Soc Nephrol. 2015 Dec;26(12):2898-901. doi: 10.1681/ASN.2015030245. Epub 2015 Apr 29.
9
Early corticosteroid avoidance in kidney transplant recipients receiving ATG-F induction: 5-year actual results of a prospective and randomized study.肾移植受者接受 ATG-F 诱导时早期避免使用皮质类固醇:一项前瞻性随机研究的 5 年实际结果。
Am J Transplant. 2014 Nov;14(11):2556-64. doi: 10.1111/ajt.12866. Epub 2014 Sep 19.
10
Big data in organ transplantation: registries and administrative claims.器官移植中的大数据:登记处与行政索赔数据
Am J Transplant. 2014 Aug;14(8):1723-30. doi: 10.1111/ajt.12777.